KALA BIO, Inc. ( KALA) - Key Metrics
KALA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.02 | -$0.02 | -$0.02 |
| 2026Q1 | $0 | -$0.20 | -$0.36 | -$0.36 |
| 2025Q4 | $0 | $0.08 | -$0.56 | -$0.56 |
| 2025Q3 | $0 | -$1.07 | -$1.54 | -$1.54 |
| 2025Q2 | $0 | -$1.71 | -$1.19 | -$1.19 |
KALA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.02 |
| 2026Q1 | 0% | -10.81 |
| 2025Q4 | 0% | 82.54 |
| 2025Q3 | 0% | -17.87 |
| 2025Q2 | 0% | -34.80 |
KALA
Price: $0.19
52 week price:
Earnings Per Share: -9.39 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 3.0 million
Ebitda: -9.9 millionMarket Capitalization: 7.0 million